JP2024507827A5 - - Google Patents

Info

Publication number
JP2024507827A5
JP2024507827A5 JP2023550015A JP2023550015A JP2024507827A5 JP 2024507827 A5 JP2024507827 A5 JP 2024507827A5 JP 2023550015 A JP2023550015 A JP 2023550015A JP 2023550015 A JP2023550015 A JP 2023550015A JP 2024507827 A5 JP2024507827 A5 JP 2024507827A5
Authority
JP
Japan
Prior art keywords
inventions described
inventions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023550015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507827A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/017043 external-priority patent/WO2022178292A1/en
Publication of JP2024507827A publication Critical patent/JP2024507827A/ja
Publication of JP2024507827A5 publication Critical patent/JP2024507827A5/ja
Pending legal-status Critical Current

Links

JP2023550015A 2021-02-18 2022-02-18 病原性生物を抑制するための組成物及び方法 Pending JP2024507827A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163151003P 2021-02-18 2021-02-18
US63/151,003 2021-02-18
PCT/US2022/017043 WO2022178292A1 (en) 2021-02-18 2022-02-18 Compositions and methods for suppressing pathogenic organisms

Publications (2)

Publication Number Publication Date
JP2024507827A JP2024507827A (ja) 2024-02-21
JP2024507827A5 true JP2024507827A5 (cg-RX-API-DMAC7.html) 2025-02-27

Family

ID=80685400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023550015A Pending JP2024507827A (ja) 2021-02-18 2022-02-18 病原性生物を抑制するための組成物及び方法

Country Status (5)

Country Link
US (1) US20240316119A1 (cg-RX-API-DMAC7.html)
EP (1) EP4294413A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024507827A (cg-RX-API-DMAC7.html)
CN (1) CN117202919A (cg-RX-API-DMAC7.html)
WO (1) WO2022178292A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021030198A1 (en) * 2019-08-09 2021-02-18 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
EP4658287A1 (en) * 2023-01-30 2025-12-10 MRM Health N.V. Microbial compositions for treating joint inflammation
EP4438051A1 (en) * 2023-03-28 2024-10-02 Biome Inc. Microbiome-based composition for preventing and treating multidrug resistant bacterial infections
CN118580989B (zh) * 2024-03-07 2025-08-22 江南大学 一种能在非水溶性膳食纤维上形成多菌生物膜的混菌组合及多菌生物膜制备方法
CN118987051A (zh) * 2024-09-13 2024-11-22 南方医科大学南方医院 粪副拟杆菌在制备治疗移植物抗宿主病药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3261761A (en) 1962-05-07 1966-07-19 Arthur W Anderson Method of freeze drying bacterial cultures
US4205132A (en) 1978-07-17 1980-05-27 Microlife Technics, Inc. Lyophilization of bacteria
CS239559B1 (sk) 1983-04-07 1986-01-16 Jozef Rusko Elektrostatická nanášacia kabina
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
WO2014029578A1 (en) 2012-08-24 2014-02-27 Haldor Topsøe A/S Method and catalyzed filter element with improved alkali-resistance for flue gas cleaning
EP2951283A4 (en) * 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
WO2015156419A1 (en) 2014-04-10 2015-10-15 Riken Compositions and methods for induction of th17 cells
EA201890097A1 (ru) 2015-06-22 2018-07-31 Президент Энд Феллоуз Оф Гарвард Колледж Индукция регуляторных т-клеток lamina propria
KR102658297B1 (ko) * 2016-06-14 2024-04-18 베단타 바이오사이언시즈, 인크. 클로스트리디움 디피실레 감염의 치료
AU2018365071B2 (en) 2017-11-09 2025-09-11 Vedanta Biosciences, Inc. Compositions and methods for the treatment of allergy
EP4410954A3 (en) * 2017-12-11 2025-01-15 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
CN116077533A (zh) * 2019-07-19 2023-05-09 芬奇治疗控股有限责任公司 用于治疗胃肠道病症的方法及产品

Similar Documents

Publication Publication Date Title
JP2023085489A5 (cg-RX-API-DMAC7.html)
JP2023105131A5 (cg-RX-API-DMAC7.html)
JP2022068302A5 (cg-RX-API-DMAC7.html)
JP2021151238A5 (cg-RX-API-DMAC7.html)
JP2023116721A5 (cg-RX-API-DMAC7.html)
JP2023052878A5 (cg-RX-API-DMAC7.html)
JP2023022224A5 (cg-RX-API-DMAC7.html)
JP2021048879A5 (cg-RX-API-DMAC7.html)
JP2024016014A5 (cg-RX-API-DMAC7.html)
JP2025506484A5 (cg-RX-API-DMAC7.html)
JP2023100643A5 (cg-RX-API-DMAC7.html)
JP2022060295A5 (cg-RX-API-DMAC7.html)
JP2021100406A5 (cg-RX-API-DMAC7.html)
JP2022544380A5 (cg-RX-API-DMAC7.html)
JP2021129286A5 (cg-RX-API-DMAC7.html)
JP2024534771A5 (cg-RX-API-DMAC7.html)
JP2023011759A5 (cg-RX-API-DMAC7.html)
JP2023041070A5 (cg-RX-API-DMAC7.html)
JP2020141705A5 (cg-RX-API-DMAC7.html)
JP2022122912A5 (cg-RX-API-DMAC7.html)
JP2025138639A5 (cg-RX-API-DMAC7.html)
JP2023182736A5 (cg-RX-API-DMAC7.html)
JP2026004274A5 (cg-RX-API-DMAC7.html)
JP2023084138A5 (cg-RX-API-DMAC7.html)
JP2022172276A5 (cg-RX-API-DMAC7.html)